arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

AtaiBeckley Inc.

ATAI
$7.25 ▲ +0.04 (+0.56%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
4 Visible periods
26 Metrics
Peer-ranked Benchmarks
Price Chart
14
Health
Poor
Bearish
auto_awesome

Analytical Summary

AtaiBeckley Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap $2.6B
Dividend Yield
Revenue Growth -38.6%
Op. Margin
ROIC -15.6%
FCF / Share $-0.06
Trailing P/E
Price / Book 13.3x
FCF Yield
Debt / Equity 0.84
info Valuation on last close. End-of-day price, Aug 7, 2026.

4-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$954.00K
↓ -38.6%
Net Income Profit after all expenses
$-29.78M
↓ -12.7%
FCF / Share Free cash flow per share
$-0.06
↑ +42.6%
Long-Term Debt Long-term obligations
$0.00
↓ -100.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
0
Financial Health
25
Cash Quality
28

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 2 years · 4 quarters